Patients
Why patient safety doesn't end at approval
Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
Market Access
Sponsored
Due diligence: Identifying start-up risks & gaps
hVIVO's Consulting team discusses due diligence, a structured assessment process to evaluate an asset's risk, opportunities, and value drivers.
Digital
Changing Faces: Digital and supplier hires, August 2026
Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.
Sales & Marketing
The patient communication crisis pharma can no longer ignore
Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.
Sales & Marketing
Headcount is not a growth strategy
Deciding when, where, and how quickly to add headcount is rarely straightforward.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
